Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Andrew K Balo. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Andrew K Balo har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:GCTK / GlucoTrack, Inc. | Director | 4 490 |
US:DXCM / DexCom, Inc. | EVP Regulatory Strategy Clinic | 50 908 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Andrew K Balo. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp GCTK / GlucoTrack, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i GCTK / GlucoTrack, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i GCTK / GlucoTrack, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Andrew K Balo som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-28 |
|
4 | GCTK |
Glucotrack, Inc.
Common Stock, par value $0.001 per share |
A - Award | 4 490 | 4 490 | |||||
2023-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −5 990 | 50 908 | −10,53 | 111,40 | −667 280 | 5 671 100 | |
2023-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 405 | 56 898 | −4,06 | 111,40 | −267 915 | 6 338 380 | |
2023-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 275 | 59 303 | −5,23 | 111,40 | −364 832 | 6 606 295 | |
2022-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −949 | 15 615 | −5,73 | 406,06 | −385 348 | 6 340 575 | |
2022-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −1 549 | 16 564 | −8,55 | 406,06 | −628 982 | 6 725 923 | |
2022-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −932 | 18 113 | −4,89 | 406,06 | −378 445 | 7 354 905 | |
2022-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 4 984 | 19 045 | 35,45 | 0,00 | 5 | 19 | |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −50 | 7 553 | −0,66 | 551,45 | −27 572 | 4 165 102 |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 200 | 7 603 | −13,63 | 550,36 | −660 433 | 4 184 396 |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 261 | 8 803 | −12,53 | 549,43 | −692 837 | 4 836 672 |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −750 | 10 064 | −6,94 | 548,24 | −411 179 | 5 517 468 |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −550 | 10 814 | −4,84 | 547,35 | −301 040 | 5 919 002 |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −50 | 11 364 | −0,44 | 543,66 | −27 183 | 6 178 152 |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −200 | 11 414 | −1,72 | 542,83 | −108 566 | 6 195 862 |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −273 | 11 614 | −2,30 | 541,33 | −147 782 | 6 286 972 |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −15 | 11 887 | −0,13 | 541,76 | −8 126 | 6 439 901 | |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −1 248 | 11 902 | −9,49 | 541,36 | −675 617 | 6 443 267 | |
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 2 498 | 13 150 | 23,45 | ||||
2021-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −2 498 | 14 056 | −15,09 | ||||
2021-08-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −349 | 10 652 | −3,17 | 519,92 | −181 452 | 5 538 181 |
2021-08-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −525 | 11 001 | −4,55 | 519,24 | −272 598 | 5 712 106 |
2021-08-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −200 | 11 526 | −1,71 | 518,06 | −103 611 | 5 971 120 |
2021-08-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −200 | 11 726 | −1,68 | 516,72 | −103 344 | 6 059 088 |
2021-08-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −300 | 11 926 | −2,45 | 515,33 | −154 598 | 6 145 786 |
2021-08-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −300 | 12 226 | −2,40 | 514,18 | −154 253 | 6 286 329 |
2021-08-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −200 | 12 526 | −1,57 | 512,83 | −102 566 | 6 423 677 |
2021-08-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −683 | 12 726 | −5,09 | 512,19 | −349 824 | 6 518 094 |
2021-07-08 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −286 | 13 409 | −2,09 | 432,05 | −123 566 | 5 793 330 |
2021-07-08 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 710 | 13 695 | −11,10 | 430,56 | −736 253 | 5 896 486 |
2021-07-08 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −400 | 15 405 | −2,53 | 429,33 | −171 732 | 6 613 844 |
2021-07-08 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −578 | 15 805 | −3,53 | 428,51 | −247 676 | 6 772 531 |
2021-06-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 391 | 16 383 | −12,74 | 375,00 | −896 625 | 6 143 625 |
2021-06-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 18 774 | 18 774 | |||||
2021-06-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −18 774 | 16 533 | −53,17 | ||||
2021-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 566 | 35 307 | −13,62 | 362,92 | −2 019 996 | 12 813 511 | |
2021-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 5 301 | 40 873 | 14,90 | 0,00 | 5 | 41 | |
2020-09-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 256 | 35 567 | −12,88 | 397,35 | −2 088 490 | 14 132 672 |
2020-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −3 297 | 40 823 | −7,47 | 398,30 | −1 313 202 | 16 259 883 | |
2020-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −1 283 | 44 120 | −2,83 | 398,30 | −511 021 | 17 573 084 | |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −250 | 45 376 | −0,55 | 370,39 | −92 598 | 16 806 998 |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 239 | 45 626 | −4,68 | 370,05 | −828 533 | 16 883 728 |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −300 | 47 865 | −0,62 | 368,29 | −110 488 | 17 628 282 |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −250 | 48 165 | −0,52 | 367,18 | −91 796 | 17 685 321 |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −400 | 48 415 | −0,82 | 366,62 | −146 649 | 17 750 082 |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 402 | 48 815 | −2,79 | 365,03 | −511 772 | 17 818 944 |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −205 | 50 217 | −0,41 | 363,46 | −74 510 | 18 252 082 |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −776 | 50 422 | −1,52 | 362,72 | −281 469 | 18 288 937 |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −200 | 51 198 | −0,39 | 361,45 | −72 290 | 18 505 517 |
2020-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −500 | 51 398 | −0,96 | 359,98 | −179 990 | 18 502 303 |
2020-04-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −51 | 51 898 | −0,10 | 287,75 | −14 675 | 14 933 650 |
2020-04-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −730 | 51 949 | −1,39 | 286,24 | −208 956 | 14 869 939 |
2020-04-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 385 | 52 679 | −4,33 | 285,14 | −680 065 | 15 021 022 |
2020-04-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 110 | 55 064 | −1,98 | 284,19 | −315 456 | 15 648 886 |
2020-04-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 382 | 56 174 | −2,40 | 281,10 | −388 477 | 15 790 377 |
2020-04-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 032 | 57 556 | −1,76 | 279,33 | −288 266 | 16 076 962 |
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −7 840 | 58 588 | −11,80 | 265,43 | −2 080 940 | 15 550 778 | |
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −319 | 66 428 | −0,48 | 250,15 | −79 799 | 16 617 250 | |
2020-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 | 66 747 | 0,00 | 246,18 | −492 | 16 432 070 | |
2020-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 8 811 | 66 749 | 15,21 | 0,00 | 9 | 67 | |
2019-09-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 386 | 57 916 | −3,96 | 151,46 | −361 384 | 8 771 957 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −244 | 60 302 | −0,40 | 159,92 | −39 021 | 9 643 562 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −269 | 60 546 | −0,44 | 158,42 | −42 615 | 9 591 631 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −450 | 60 815 | −0,73 | 157,78 | −70 999 | 9 595 099 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −550 | 61 265 | −0,89 | 156,43 | −86 039 | 9 583 960 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −100 | 61 815 | −0,16 | 155,36 | −15 536 | 9 603 269 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −40 | 61 915 | −0,06 | 154,00 | −6 160 | 9 534 755 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −600 | 61 955 | −0,96 | 152,59 | −91 554 | 9 453 720 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −621 | 62 555 | −0,98 | 151,49 | −94 077 | 9 476 582 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −279 | 63 176 | −0,44 | 150,52 | −41 996 | 9 509 365 |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 629 | 63 455 | −8,15 | 150,11 | −844 975 | 9 525 300 | |
2019-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −325 | 69 084 | −0,47 | 145,43 | −47 264 | 10 046 624 | |
2019-09-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −37 | 69 409 | −0,05 | 170,00 | −6 290 | 11 799 530 |
2019-06-06 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 825 | 69 392 | −10,13 | 125,00 | −978 125 | 8 674 000 |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 296 | 77 217 | −2,89 | 142,79 | −327 851 | 11 025 985 | |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −6 399 | 79 513 | −7,45 | 142,79 | −913 727 | 11 353 836 | |
2019-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 222 | 85 912 | −2,52 | 142,79 | −317 284 | 12 267 563 | |
2019-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 14 987 | 88 134 | 20,49 | 0,00 | 15 | 88 | |
2018-12-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 373 | 73 105 | −5,64 | 121,38 | −530 782 | 8 873 280 |
2018-12-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −627 | 77 478 | −0,80 | 120,23 | −75 384 | 9 315 195 |
2018-11-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 498 | 78 105 | −1,88 | 144,43 | −216 359 | 11 280 830 |
2018-11-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 502 | 79 603 | −1,85 | 143,88 | −216 101 | 11 452 898 |
2018-11-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −800 | 81 105 | −0,98 | 142,13 | −113 704 | 11 527 454 |
2018-11-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 200 | 81 905 | −1,44 | 141,25 | −169 501 | 11 569 147 |
2018-10-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 009 | 83 105 | −2,36 | 125,24 | −251 598 | 10 407 680 |
2018-10-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 991 | 85 114 | −3,39 | 124,49 | −372 336 | 10 595 450 |
2018-09-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 400 | 88 105 | −4,76 | 145,27 | −639 174 | 12 798 740 |
2018-09-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −600 | 92 505 | −0,64 | 144,46 | −86 677 | 13 363 439 |
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −3 180 | 93 105 | −3,30 | 143,76 | −457 142 | 13 384 328 | |
2018-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 407 | 96 285 | −2,44 | 143,76 | −346 019 | 13 841 469 | |
2018-08-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −550 | 98 567 | −0,55 | 124,96 | −68 727 | 12 316 755 |
2018-08-16 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 450 | 99 117 | −4,30 | 124,16 | −552 526 | 12 306 674 |
2018-07-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −500 | 103 567 | −0,48 | 100,73 | −50 365 | 10 432 304 |
2018-07-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 800 | 104 067 | −1,70 | 99,90 | −179 823 | 10 396 439 |
2018-07-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 700 | 105 867 | −2,49 | 99,12 | −267 628 | 10 493 696 |
2018-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 464 | 108 567 | −3,95 | 60,73 | −271 101 | 6 593 339 | |
2018-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 221 | 113 031 | −1,93 | 60,73 | −134 883 | 6 864 440 | |
2018-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 834 | 115 252 | −2,40 | 60,73 | −172 111 | 6 999 323 | |
2018-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 38 502 | 118 086 | 48,38 | 0,00 | 39 | 118 | |
2017-12-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 245 | 79 547 | −3,92 | 61,23 | −198 691 | 4 870 663 |
2017-11-30 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −6 490 | 82 792 | −7,27 | 60,00 | −389 400 | 4 967 520 |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 347 | 89 282 | −3,61 | 71,81 | −240 359 | 6 411 644 | |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 184 | 92 629 | −4,32 | 71,81 | −300 467 | 6 652 003 | |
2017-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 244 | 96 813 | −3,24 | 72,27 | −234 441 | 6 996 598 |
2017-08-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 244 | 99 989 | −3,14 | 71,18 | −230 921 | 7 117 627 |
2017-07-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 200 | 103 233 | −3,01 | 71,55 | −228 972 | 7 386 724 |
2017-06-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 200 | 106 433 | −2,92 | 69,06 | −220 989 | 7 350 157 |
2017-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 200 | 109 633 | −2,84 | 71,93 | −230 176 | 7 885 902 |
2017-04-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 200 | 112 833 | −2,76 | 78,19 | −250 208 | 8 822 412 |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 208 | 116 033 | −2,69 | 77,55 | −248 782 | 8 998 429 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 694 | 119 241 | −5,32 | 77,55 | −519 124 | 9 247 211 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 528 | 125 935 | −2,73 | 77,55 | −273 599 | 9 766 335 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 200 | 129 463 | −2,41 | 77,71 | −248 672 | 10 060 570 |
2017-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 28 761 | 132 663 | 27,68 | 0,00 | 29 | 133 | |
2017-02-14 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −727 | 0 | −100,00 | 79,30 | −57 651 | ||
2017-02-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 473 | 103 872 | −2,33 | 79,30 | −196 109 | 8 237 050 |
2017-02-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −727 | 106 345 | −0,68 | 79,30 | −57 651 | 8 433 158 |
2017-02-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 727 | 107 072 | 0,68 | 9,80 | 7 125 | 1 049 306 | |
2017-01-12 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −3 200 | 727 | −81,49 | 62,86 | −201 152 | 45 699 | |
2017-01-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 200 | 106 345 | −2,92 | 62,86 | −201 152 | 6 684 847 |
2017-01-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 3 200 | 109 545 | 3,01 | 9,80 | 31 360 | 1 073 541 | |
2016-10-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 997 | 106 345 | −4,49 | 82,31 | −411 303 | 8 753 257 |
2016-10-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 111 342 | −4,30 | 82,55 | −412 750 | 9 191 282 |
2016-09-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 116 342 | −4,12 | 92,87 | −464 366 | 10 805 054 |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 223 | 121 342 | −3,36 | 93,72 | −395 791 | 11 372 488 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 445 | 125 565 | −3,42 | 93,72 | −416 597 | 11 768 278 | |
2016-09-09 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 999 | 0 | −100,00 | 94,45 | −472 156 | ||
2016-09-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 999 | 130 010 | −3,70 | 94,45 | −472 156 | 12 279 444 |
2016-09-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 999 | 135 009 | 3,85 | 3,19 | 15 947 | 430 679 | |
2016-08-26 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 4 999 | −50,01 | 91,72 | −458 600 | 458 508 | |
2016-08-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 129 979 | −3,70 | 91,72 | −458 600 | 11 921 674 |
2016-08-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 134 979 | 3,85 | 3,19 | 15 950 | 430 583 | |
2016-08-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 9 999 | −33,34 | 90,26 | −451 300 | 902 510 | |
2016-08-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 129 979 | −3,70 | 90,26 | −451 300 | 11 731 905 |
2016-08-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 134 979 | 3,85 | 3,19 | 15 950 | 430 583 | |
2016-07-28 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 14 999 | −25,00 | 88,14 | −440 700 | 1 322 012 | |
2016-07-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 129 979 | −3,70 | 88,14 | −440 700 | 11 456 349 |
2016-07-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 134 979 | 3,85 | 3,19 | 15 950 | 430 583 | |
2016-07-14 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 19 999 | −20,00 | 80,12 | −400 600 | 1 602 320 | |
2016-07-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 129 979 | −3,70 | 80,12 | −400 600 | 10 413 917 |
2016-07-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 134 979 | 3,85 | 3,19 | 15 950 | 430 583 | |
2016-07-01 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 24 999 | −16,67 | 78,10 | −390 500 | 1 952 422 | |
2016-07-01 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 129 979 | −3,70 | 78,10 | −390 500 | 10 151 360 |
2016-07-01 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 134 979 | 3,85 | 3,19 | 15 950 | 430 583 | |
2016-06-20 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −55 000 | 29 999 | −64,71 | 75,00 | −4 125 000 | 2 249 925 | |
2016-06-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −55 000 | 129 979 | −29,73 | 75,00 | −4 125 000 | 9 748 425 |
2016-06-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 55 000 | 184 979 | 42,31 | 3,19 | 175 450 | 590 083 | |
2016-03-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 430 | 129 979 | −3,30 | 63,96 | −283 348 | 8 313 613 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 040 | 134 409 | −5,64 | 63,18 | −507 967 | 8 491 961 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 328 | 142 449 | −2,28 | 63,18 | −210 263 | 8 999 928 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 38 000 | 145 777 | 35,26 | 0,00 | 38 | 146 | |
2015-12-21 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 84 999 | −8,11 | 82,52 | −618 869 | 7 013 769 | |
2015-12-21 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 107 680 | −6,51 | 82,52 | −618 869 | 8 885 312 |
2015-12-21 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 115 180 | 6,97 | 3,19 | 23 925 | 367 424 | |
2015-12-04 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 92 499 | −7,50 | 86,37 | −647 781 | 7 989 213 | |
2015-12-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 107 680 | −6,51 | 86,37 | −647 781 | 9 300 408 |
2015-12-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 115 180 | 6,97 | 3,19 | 23 925 | 367 424 | |
2015-11-30 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 99 999 | −6,98 | 87,49 | −656 192 | 8 749 133 | |
2015-11-30 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 107 680 | −6,51 | 87,49 | −656 192 | 9 421 160 |
2015-11-30 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 115 180 | 6,97 | 3,19 | 23 925 | 367 424 | |
2015-11-24 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 800 | 107 499 | −4,27 | 86,36 | −414 534 | 9 283 743 | |
2015-11-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
G - Gift | −5 477 | 107 680 | −4,84 | ||||
2015-11-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −4 800 | 113 157 | −4,07 | 86,36 | −414 534 | 9 772 374 | |
2015-11-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 800 | 117 957 | 4,24 | 3,19 | 15 312 | 376 283 | |
2015-11-24 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 200 | 112 299 | −4,43 | 86,50 | −449 800 | 9 713 864 | |
2015-11-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 200 | 113 157 | −4,39 | 86,50 | −449 800 | 9 788 080 | |
2015-11-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 200 | 118 357 | 4,60 | 3,19 | 16 588 | 377 559 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 117 499 | −6,00 | 84,50 | −633 734 | 9 928 419 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 113 157 | −6,22 | 84,50 | −633 734 | 9 561 529 |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 120 657 | 6,63 | 3,19 | 23 925 | 384 896 | |
2015-10-21 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 538 | 113 157 | −3,86 | 81,46 | −369 670 | 9 217 882 |
2015-10-07 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −8 216 | 117 695 | −6,53 | 82,29 | −676 083 | 9 684 957 |
2015-09-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 859 | 125 911 | −5,88 | 100,72 | −791 570 | 12 681 945 |
2015-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 416 | 133 770 | −3,20 | 95,93 | −423 638 | 12 832 904 | |
2015-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 404 | 138 186 | −3,09 | 90,90 | −400 317 | 12 560 900 | |
2015-09-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 142 590 | −5,00 | 89,53 | −671 446 | 12 765 541 |
2015-08-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 150 090 | −4,76 | 92,47 | −693 500 | 13 878 312 |
2015-08-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 157 590 | −4,54 | 95,04 | −712 774 | 14 976 818 |
2015-07-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 214 | 165 033 | −5,83 | 84,78 | −865 922 | 13 991 168 |
2015-07-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 494 | 175 247 | −2,50 | 80,22 | −360 510 | 14 058 349 |
2015-06-25 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 573 | 0 | −100,00 | 77,54 | −432 137 | ||
2015-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 573 | 179 741 | −3,01 | 77,54 | −432 137 | 13 937 315 |
2015-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 573 | 185 314 | 3,10 | 9,80 | 54 615 | 1 816 077 | |
2015-06-11 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 5 573 | −57,37 | 70,62 | −529 659 | 393 572 | |
2015-06-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 179 741 | −4,01 | 70,62 | −529 659 | 12 693 525 |
2015-06-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 187 241 | 4,17 | 9,80 | 73 500 | 1 834 962 | |
2015-05-20 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 13 073 | −36,46 | 68,46 | −513 470 | 895 012 | |
2015-05-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 179 741 | −4,01 | 68,46 | −513 470 | 12 305 536 |
2015-05-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 187 241 | 4,17 | 9,80 | 73 500 | 1 834 962 | |
2015-05-05 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 20 573 | −26,72 | 67,99 | −509 903 | 1 398 699 | |
2015-05-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 179 741 | −4,01 | 67,99 | −509 903 | 12 220 069 |
2015-05-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 187 241 | 4,17 | 9,80 | 73 500 | 1 834 962 | |
2015-04-27 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 28 073 | −21,08 | 69,65 | −522 353 | 1 955 203 | |
2015-04-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 179 741 | −4,01 | 69,65 | −522 353 | 12 518 439 |
2015-04-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 187 241 | 4,17 | 9,80 | 73 500 | 1 834 962 | |
2015-04-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 35 573 | −17,41 | 64,55 | −484 149 | 2 296 351 | |
2015-04-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 179 741 | −4,01 | 64,55 | −484 149 | 11 602 857 |
2015-04-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 187 241 | 4,17 | 9,80 | 73 500 | 1 834 962 | |
2015-03-27 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 43 073 | −14,83 | 61,05 | −457 849 | 2 629 456 | |
2015-03-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 179 741 | −4,01 | 61,05 | −457 849 | 10 972 559 |
2015-03-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 187 241 | 4,17 | 9,80 | 73 500 | 1 834 962 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 448 | 179 741 | −2,41 | 58,58 | −260 548 | 10 528 599 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 50 573 | −12,91 | 58,58 | −439 367 | 2 962 683 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 184 189 | −3,91 | 58,58 | −439 367 | 10 790 215 |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 191 689 | 4,07 | 9,80 | 73 500 | 1 878 552 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 824 | 184 189 | −4,57 | 58,74 | −518 324 | 10 819 299 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 743 | 193 013 | −2,40 | 58,74 | −278 605 | 11 337 622 | |
2015-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 47 500 | 197 756 | 31,61 | 0,00 | 48 | 198 | |
2015-02-26 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 58 073 | −11,44 | 62,22 | −466 636 | 3 613 198 | |
2015-02-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 150 256 | −4,75 | 62,22 | −466 636 | 9 348 658 |
2015-02-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 157 756 | 4,99 | 9,80 | 73 500 | 1 546 009 | |
2015-02-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 500 | 65 573 | −10,26 | 61,41 | −460 606 | 4 027 113 | |
2015-02-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 500 | 150 256 | −4,75 | 61,41 | −460 606 | 9 227 852 |
2015-02-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 500 | 157 756 | 4,99 | 9,80 | 73 500 | 1 546 009 | |
2015-01-28 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | 59,25 | −592 453 | ||
2015-01-28 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −5 000 | 3 927 | −56,01 | 59,25 | −296 226 | 232 656 | |
2015-01-28 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −1 | 0 | −100,00 | 59,25 | −59 | ||
2015-01-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 150 130 | −6,24 | 59,25 | −592 453 | 8 894 497 |
2015-01-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 160 130 | 6,66 | 7,63 | 76 300 | 1 221 792 | |
2015-01-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 | 150 130 | 0,00 | 59,25 | −59 | 8 894 497 |
2015-01-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 1 | 150 131 | 0,00 | 3,19 | 3 | 478 918 | |
2015-01-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 150 130 | −3,22 | 59,25 | −296 226 | 8 894 497 |
2015-01-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 155 130 | 3,33 | 9,80 | 49 000 | 1 520 274 | |
2014-12-30 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 10 000 | −50,00 | 55,27 | −552 687 | 552 687 | |
2014-12-30 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 150 130 | −6,24 | 55,27 | −552 687 | 8 297 490 |
2014-12-30 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 160 130 | 6,66 | 7,63 | 76 300 | 1 221 792 | |
2014-12-15 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 20 000 | −33,33 | 55,42 | −554 195 | 1 108 390 | |
2014-12-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 150 130 | −6,24 | 55,42 | −554 195 | 8 320 130 |
2014-12-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 160 130 | 6,66 | 7,63 | 76 300 | 1 221 792 | |
2014-11-26 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 30 000 | −25,00 | 51,11 | −511 138 | 1 533 414 | |
2014-11-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 150 130 | −6,24 | 51,11 | −511 138 | 7 673 715 |
2014-11-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 160 130 | 6,66 | 7,63 | 76 300 | 1 221 792 | |
2014-11-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 40 000 | −20,00 | 52,93 | −529 295 | 2 117 180 | |
2014-11-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 150 130 | −6,24 | 52,93 | −529 295 | 7 946 306 |
2014-11-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 160 130 | 6,66 | 7,63 | 76 300 | 1 221 792 | |
2014-10-28 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 50 000 | −16,67 | 42,98 | −429 755 | 2 148 775 | |
2014-10-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 150 130 | −6,24 | 42,98 | −429 755 | 6 451 912 |
2014-10-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 160 130 | 6,66 | 7,63 | 76 300 | 1 221 792 | |
2014-10-14 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 60 000 | −14,29 | 40,42 | −404 165 | 2 424 990 | |
2014-10-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 150 130 | −6,24 | 40,42 | −404 165 | 6 067 729 |
2014-10-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 160 130 | 6,66 | 7,63 | 76 300 | 1 221 792 | |
2014-09-25 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 70 000 | −12,50 | 40,71 | −407 072 | 2 849 504 | |
2014-09-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 150 130 | −6,24 | 40,71 | −407 072 | 6 111 372 |
2014-09-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 160 130 | 6,66 | 7,63 | 76 300 | 1 221 792 | |
2014-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 404 | 150 130 | −2,85 | 43,36 | −190 968 | 6 509 997 | |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 582 | 80 000 | −10,70 | 42,97 | −411 744 | 3 437 648 | |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −418 | 0 | −100,00 | 42,97 | −17 962 | ||
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −9 582 | 154 534 | −5,84 | 42,97 | −411 744 | 6 640 419 |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 9 582 | 164 116 | 6,20 | 7,63 | 73 111 | 1 252 205 | |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −418 | 154 534 | −0,27 | 42,97 | −17 962 | 6 640 419 |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 418 | 154 952 | 0,27 | 7,63 | 3 189 | 1 182 284 | |
2014-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 671 | 154 534 | −2,93 | 43,23 | −201 937 | 6 680 829 | |
2014-08-27 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −10 000 | 418 | −95,99 | 44,12 | −441 243 | 18 444 | |
2014-08-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 205 | −5,91 | 44,12 | −441 243 | 7 024 809 |
2014-08-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 205 | 6,28 | 7,63 | 76 300 | 1 291 034 | |
2014-08-25 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 000 | 124 999 | −13,79 | 44,24 | −884 722 | 5 529 468 | |
2014-08-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −20 000 | 159 205 | −11,16 | 44,24 | −884 722 | 7 042 608 | |
2014-08-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 20 000 | 179 205 | 12,56 | 3,19 | 63 800 | 571 664 | |
2014-08-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | 44,24 | −442 373 | ||
2014-08-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 205 | −5,91 | 44,24 | −442 373 | 7 042 799 |
2014-08-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 205 | 6,28 | 8,94 | 89 400 | 1 512 693 | |
2014-07-29 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 10 000 | −50,00 | 38,19 | −381 857 | 381 857 | |
2014-07-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 099 | −5,91 | 38,19 | −381 857 | 6 075 307 |
2014-07-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 099 | 6,29 | 8,94 | 89 400 | 1 511 745 | |
2014-07-15 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 20 000 | −33,33 | 35,93 | −359 347 | 718 694 | |
2014-07-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 099 | −5,91 | 35,93 | −359 347 | 5 717 175 |
2014-07-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 099 | 6,29 | 8,94 | 89 400 | 1 511 745 | |
2014-06-25 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 30 000 | −25,00 | 40,60 | −405 982 | 1 217 946 | |
2014-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 099 | −5,91 | 40,60 | −405 982 | 6 459 133 |
2014-06-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 099 | 6,29 | 8,94 | 89 400 | 1 511 745 | |
2014-06-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 616 | 40 000 | −6,14 | 36,63 | −95 825 | 1 465 220 | |
2014-06-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −7 384 | 0 | −100,00 | 36,63 | −270 480 | ||
2014-06-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 384 | 159 099 | −4,44 | 36,63 | −270 480 | 5 827 876 |
2014-06-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 384 | 166 483 | 4,64 | 8,94 | 66 013 | 1 488 358 | |
2014-06-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 616 | 159 099 | −1,62 | 36,63 | −95 825 | 5 827 876 |
2014-06-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 2 616 | 161 715 | 1,64 | 8,94 | 23 387 | 1 445 732 | |
2014-05-28 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | 33,86 | −338 638 | ||
2014-05-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 099 | −5,91 | 33,86 | −338 638 | 5 387 697 |
2014-05-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 099 | 6,29 | 7,25 | 72 500 | 1 225 968 | |
2014-05-14 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 10 000 | −50,00 | 31,75 | −317 499 | 317 499 | |
2014-05-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 099 | −5,91 | 31,75 | −317 499 | 5 051 377 |
2014-05-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 099 | 6,29 | 7,25 | 72 500 | 1 225 968 | |
2014-04-29 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 20 000 | −33,33 | 34,35 | −343 460 | 686 920 | |
2014-04-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 099 | −5,91 | 34,35 | −343 460 | 5 464 414 |
2014-04-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 099 | 6,29 | 7,25 | 72 500 | 1 225 968 | |
2014-04-15 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 30 000 | −25,00 | 35,36 | −353 564 | 1 060 692 | |
2014-04-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 099 | −5,91 | 35,36 | −353 564 | 5 625 168 |
2014-04-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 099 | 6,29 | 7,25 | 72 500 | 1 225 968 | |
2014-03-26 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 40 000 | −20,00 | 43,00 | −429 964 | 1 719 856 | |
2014-03-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 159 099 | −5,91 | 43,00 | −429 964 | 6 840 684 |
2014-03-26 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 169 099 | 6,29 | 7,25 | 72 500 | 1 225 968 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 054 | 50 000 | −9,18 | 45,93 | −232 114 | 2 296 335 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 946 | 0 | −100,00 | 45,93 | −227 153 | ||
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 808 | 159 099 | −5,25 | 45,22 | −398 312 | 7 194 711 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 946 | 167 907 | −2,86 | 45,93 | −227 153 | 7 711 414 |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 946 | 172 853 | 2,95 | 7,25 | 35 858 | 1 253 184 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 054 | 167 907 | −2,92 | 45,93 | −232 114 | 7 711 414 |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 054 | 172 961 | 3,01 | 7,25 | 36 642 | 1 253 967 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 578 | 167 907 | −3,77 | 46,10 | −303 255 | 7 740 748 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 50 000 | 174 485 | 40,17 | 0,00 | 50 | 174 | |
2014-02-27 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −10 000 | 4 946 | −66,91 | 44,97 | −449 690 | 222 417 | |
2014-02-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 124 485 | −7,44 | 44,97 | −449 690 | 5 597 966 |
2014-02-27 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 134 485 | 8,03 | 7,25 | 72 500 | 975 016 | |
2014-02-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | 39,50 | −197 487 | ||
2014-02-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | 39,50 | −197 487 | ||
2014-02-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 124 485 | −3,86 | 39,50 | −197 487 | 4 916 834 |
2014-02-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 000 | 124 485 | −3,86 | 39,50 | −197 487 | 4 916 834 |
2014-02-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 129 485 | 4,02 | 7,25 | 36 250 | 938 766 | |
2014-02-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 5 000 | 129 485 | 4,02 | 14,30 | 71 500 | 1 851 636 | |
2014-01-29 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 078 | 5 000 | −54,87 | 36,67 | −222 854 | 183 328 | |
2014-01-29 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −3 922 | 0 | −100,00 | 36,67 | −143 802 | ||
2014-01-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 922 | 124 297 | −3,06 | 36,67 | −143 802 | 4 557 424 |
2014-01-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 3 922 | 128 219 | 3,16 | 14,30 | 56 085 | 1 833 532 | |
2014-01-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −6 078 | 124 297 | −4,66 | 36,67 | −222 854 | 4 557 424 |
2014-01-29 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 6 078 | 130 375 | 4,89 | 14,30 | 86 915 | 1 864 362 | |
2014-01-15 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −10 000 | 3 922 | −71,83 | 37,37 | −373 696 | 146 564 | |
2014-01-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 124 297 | −7,45 | 37,37 | −373 696 | 4 644 929 |
2014-01-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 134 297 | 8,05 | 14,30 | 143 000 | 1 920 447 | |
2013-12-04 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −14 268 | 124 297 | −10,30 | 34,21 | −488 158 | 4 252 635 | |
2013-11-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −26 784 | 0 | −100,00 | 33,15 | −887 890 | ||
2013-11-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −26 784 | 138 565 | −16,20 | 33,15 | −887 890 | 4 593 430 | |
2013-11-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 26 784 | 165 349 | 19,33 | 2,40 | 64 282 | 396 838 | |
2013-11-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −15 438 | 26 784 | −36,56 | 33,17 | −512 034 | 888 348 | |
2013-11-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −15 438 | 138 565 | −10,02 | 33,17 | −512 034 | 4 595 799 | |
2013-11-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 15 438 | 154 003 | 11,14 | 2,40 | 37 051 | 369 607 | |
2013-09-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 200 | 138 565 | −4,28 | 26,89 | −166 714 | 3 725 930 | |
2013-06-17 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −10 000 | 42 222 | −19,15 | 21,90 | −219 015 | 924 725 | |
2013-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −10 000 | 144 571 | −6,47 | 21,90 | −219 015 | 3 166 322 | |
2013-06-17 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 154 571 | 6,92 | 2,40 | 24 000 | 370 970 | |
2013-05-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −45 000 | 52 222 | −46,29 | 19,40 | −873 000 | 1 013 107 | |
2013-05-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −45 000 | 144 571 | −23,74 | 19,40 | −873 000 | 2 804 677 | |
2013-05-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 45 000 | 189 571 | 31,13 | 2,40 | 108 000 | 454 970 | |
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −15 416 | 0 | −100,00 | 16,53 | −254 814 | ||
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −15 416 | 144 571 | −9,64 | 16,53 | −254 814 | 2 389 643 | |
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 15 416 | 159 987 | 10,66 | 0,50 | 7 708 | 79 994 | |
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −9 647 | 144 571 | −6,26 | 15,69 | −151 361 | 2 268 319 | |
2013-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 50 000 | 154 218 | 47,98 | 0,00 | 50 | 154 | |
2012-12-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −7 000 | 0 | −100,00 | 13,96 | −97 697 | ||
2012-12-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 760 | 103 973 | −5,25 | 13,98 | −80 528 | 1 453 595 | |
2012-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −2 734 | 109 733 | −2,43 | 13,68 | −37 392 | 1 500 774 | |
2012-05-22 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −28 466 | 0 | −100,00 | ||||
2012-05-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −14 198 | 112 308 | −11,22 | 10,46 | −148 488 | 1 174 562 | |
2012-05-22 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 28 466 | 126 506 | 29,04 | 0,50 | 14 233 | 63 253 | |
2012-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −5 582 | 98 040 | −5,39 | 10,26 | −57 262 | 1 005 724 | |
2012-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 53 750 | 103 622 | 107,78 | 0,00 | 54 | 104 |